Patient Use, Indications, and Coverage as of Sep-2014
Patient Use, Indications, and Coverage as of Sep-2014
Patient Use Data
Patients (cumulative) Over 100,000

Patient Saves 2,274

Time to treatment within 60 seconds (remaining delayed due to response button or VT programming) 73%

First shock success rate 98%

Unnecessary shock rate <1% /month of use

Shocked event survival (conscious ER arrival or remained at home) 92%

Average duration of use 72 days

Median daily use and compliance 22.5 hr/day

 
LifeVest Medicare/Medicaid and Insurance Coverage
Covered under Medicare, most state Medicaid plans, and most commercial insurance plans as Durable Medical Equipment (DME).
Number of Medicaid programs covering LifeVest 41 states

Total health plans, both commercial and state now approving reimbursement 6,580

ZOLL LifeVest Patient Use, Indications, and Coverage as of Sep-2014
LifeVest Medical Orders by Indication (Last 12 Months)
 
 
MI/NICM Breakdown
Recent MI 26%
Recent CABG 6%
Early NICM 47%
Class IV CHF 2%
Unspecified 1%

LifeVest Medical Orders by Indication (Cumulative as of Sep-2014)
 
 
MI/NICM Breakdown
Recent MI 27%
Recent CABG 8%
Early NICM 39%
Class IV CHF 2%
Unspecified 1%